[1]Patent:US2016/67260,2016,A1,.Locationinpatent:Paragraph0284
[1]CurrentPatentAssignee:MERCK&COINC-US2016/67260,2016,A1Locationinpatent:Paragraph0284
Title: Lapierre JM, et al. Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo,5-bpyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor. J Med Chem. 2016 Jul 14;59(13):6455-69.
Title: Devki Nandan, et al. Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania. PLoS One. 2018 Nov 6;13(11):e0206920.